BTG plc (LON:BTG – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 840 ($11.10) and traded as high as GBX 840 ($11.10). BTG shares last traded at GBX 840 ($11.10), with a volume of 271,742 shares changing hands.
BTG Stock Performance
The company’s 50-day moving average is GBX 840 and its 200-day moving average is GBX 840. The firm has a market cap of £3.26 billion and a price-to-earnings ratio of 29.47.
BTG Company Profile
BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.
Featured Articles
- Five stocks we like better than BTG
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Stocks That Could Rise on European Bank Interest Rate Cuts
- 3 REITs to Buy and Hold for the Long Term
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Financial Services Stocks Investing
- MarketBeat Week in Review – 9/16 – 9/20
Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.